QQ客服 官方微博 反馈留言

	RACTS: A prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting long-term clinical and angiographic outcome - Long-term clinical and angiographic outcome
	Ge, JB; Han, YL; Jiang, H; Sun, BG; Chen, JY; Zhang, SY; Du, ZM
刊名	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
	2005
卷号	46期号:2
关键词	cilostazol platelet aggregation inhibitors restenosis side effect ticlopidine
ISSN号	0160-2446
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5634193
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Ge, JB,Han, YL,Jiang, H,et al. RACTS: A prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting long-term clinical and angiographic outcome - Long-term clinical and angiographic outcome[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY,2005,46(2).
APA	Ge, JB.,Han, YL.,Jiang, H.,Sun, BG.,Chen, JY.,...&Du, ZM.(2005).RACTS: A prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting long-term clinical and angiographic outcome - Long-term clinical and angiographic outcome.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY,46(2).
MLA	Ge, JB,et al."RACTS: A prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting long-term clinical and angiographic outcome - Long-term clinical and angiographic outcome".JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 46.2(2005).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。